{
  "id": 14943500,
  "title": "Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?",
  "url": "https://urgent.news/2026/10/16/meet-the-new-nasdaq-100-stock-thats-crushing-nvidia-micron-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T11:05:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/16/meet-the-new-nasdaq-100-stock-that-s-crushing-nvidia-micron-and-sandisk-is-it-too-late-to-buy/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "The latest NASDAQ-100 stock to surpass Nvidia, Micron, and SanDisk is Moderna (MRNA), surging over 600% this year. While AI stocks continue to grow, investors have diversified into other industries, highlighting new growth prospects. Moderna, once a vaccine pioneer, now expands into oncology and rare disease treatments. After a year of setbacks, Moderna regained momentum post-pandemic, cutting costs and securing approvals for new products. Its oncology-focused pipeline, particularly the intismeran autogene cancer vaccine, holds promise for future revenue. Currently trading near $225, surpassing Wall Street's price target of $122, Moderna presents a compelling opportunity, but investors should monitor it for potential dips to capitalize on its continued growth.",
  "summary": "This stock has soared more than 600% this year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?",
        "url": "https://urgent.news/2026/10/16/meet-the-new-nasdaq-100-stock-thats-crushing-nvidia-micron-and-14952105",
        "published": "2026-10-16T11:25:02.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}